Skip to Content

BNY Mellon International Equity C NIECX

Medalist Rating as of | See BNY Mellon Investment Hub
  • NAV / 1-Day Return 21.06  /  +1.10 %
  • Total Assets 310.6 Mil
  • Adj. Expense Ratio
    1.820%
  • Expense Ratio 1.820%
  • Distribution Fee Level Below Average
  • Share Class Type Level Load
  • Category Foreign Large Blend
  • Investment Style Large Growth
  • Min. Initial Investment 1,000
  • Status Closed
  • TTM Yield 0.89%
  • Turnover 46%

USD | NAV as of Apr 26, 2024 | 1-Day Return as of Apr 26, 2024, 10:18 PM GMT+0

Morningstar’s Analysis NIECX

Will NIECX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Strength in BNY Mellon International Equity C's Process Pillar is partially offset by an Average People Pillar rating, leading to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings NIECX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 28.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

ASML Holding NV

3.95 12.8 Mil
Technology

Nestle SA

3.43 11.1 Mil
Consumer Defensive

Novo Nordisk A/S Class B

3.31 10.7 Mil
Healthcare

Lvmh Moet Hennessy Louis Vuitton SE

3.03 9.8 Mil
Consumer Cyclical

SAP SE

2.66 8.6 Mil
Technology

Novartis AG Registered Shares

2.63 8.5 Mil
Healthcare

AstraZeneca PLC

2.57 8.3 Mil
Healthcare

Air Liquide SA

2.27 7.3 Mil
Basic Materials

Wolters Kluwer NV

2.26 7.3 Mil
Industrials

Sanofi SA

2.23 7.2 Mil
Healthcare